在4.5至24小时内因大血管封闭而引起的缺血性中风的 Tenecteplase:随机对照试验的元分析
Shuangzhe Wu1, Liyuan Wang1, Zhixin Cao1
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Brain and behavior
|November 22, 2025
概括
甲可改善急性缺血性中风患者在延长4.5至24小时的窗口内大血管封闭的功能结果. 这种治疗显示出卓越的效果,使得功能恢复良好,而不会增加安全问题.
科学领域:
- 神经学 神经学
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 对于急性缺血性中风在延长时间窗口中使用丁氏甲的研究有限.
- 大型血管阻塞中风带来了独特的挑战,需要及时和有效的干预.
研究的目的:
- 为了评估tenecteplase在急性缺血性中风患者的疗效和安全性,在延长的4.5至24小时窗口内大血管封闭.
- 为了在这个特定的患者群体中比较tenacteplase治疗与对照干预措施.
主要方法:
- 进行了随机对照试验的元分析.
- 包括的试验比较了尖性缺血性中风患者的基和对照剂,大血管封闭时间在4.5至24小时之间.
- 在主要数据库中进行系统的文献搜索,截至2024年6月.
主要成果:
- 与对照组相比,tenecteplase显著提高了优秀功能结局的比率 (修改的兰金尺度0-1在90天) (OR,1.36;p=0.01).
- 较高的再通道化率被观察到与丁氏甲 (OR,3.30;p=0.001).
- 在包括死亡率和出血在内的安全结果中没有发现显著差异.
结论:
- 在大血管封闭性中风患者中,在4.5至24小时的窗口内,tenecteplase优于对照剂,可以达到优异的功能结果.
- 在这种延长的时间框架中,使用tenecteplase似乎不会引发安全问题.
相关概念视频
01:28Acute Coronary Syndrome IV: Interprofessional Care
203
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
203
01:30Acute Coronary Syndrome I: Introduction
744
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
744
01:16Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
01:29Venous Thrombosis III: Interprofessional Care
268
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
268
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
286
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
286
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
609
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
609